Published 12 days ago • loading... • Updated 9 days ago

AstraZeneca to build $2.5B research hub in Beijing

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, as announced by the company on Friday.
This center will increase AstraZeneca's workforce in Beijing to approximately 1,700, according to the company's statement.
AstraZeneca is partnering with the Beijing government and three Chinese biotech firms as part of this project.
CEO Pascal Soriot stated that this investment reflects AstraZeneca's commitment to China's life sciences ecosystem.

Insights by Ground AI

Does this summary seem wrong?

20 Articles

All

Left

Center

Right

The Telegraph

Right

AstraZeneca to invest £2bn in Beijing amid China investigation

Pharmaceutical giant scrambles to contain scandal over alleged illegal drug imports

12 days ago·London, United Kingdom

Read Full Article

UPI

Center

AstraZeneca to build $2.5B research hub in Beijing

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday.

12 days ago·Washington, United States

Read Full Article

biopharmadive.com

Center

AstraZeneca deepens China investment; Editas loses CFO to Dyne

The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.

12 days ago

Read Full Article

Financial Times

Center

AstraZeneca to invest $2.5bn in China after scandal

London-listed drugmaker will establish research centre in Beijing

12 days ago·London, United Kingdom

Read Full Article

CNBC

Center

British pharma giant AstraZeneca to invest $2.5 billion in new China hub

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in Beijing, China.

12 days ago·United States

Read Full Article

Bloomberg

Lean Left

AstraZeneca Invests $2.5 Billion in Beijing, Undeterred by Probe

AstraZeneca Plc will invest $2.5 billion in a new research center in Beijing, in a major show of commitment to China just months after the company’s top executive there was detained by authorities.

12 days ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year